Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000809533 | SCV000949686 | uncertain significance | Gastrointestinal stromal tumor | 2023-04-18 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with PDGFRA-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 653719). This variant is present in population databases (no rsID available, gnomAD 0.006%). This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 1067 of the PDGFRA protein (p.Ile1067Thr). |
Fulgent Genetics, |
RCV002501097 | SCV002814981 | uncertain significance | Idiopathic hypereosinophilic syndrome; Polyps, multiple and recurrent inflammatory fibroid, gastrointestinal | 2021-08-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV004569658 | SCV005055154 | uncertain significance | Polyps, multiple and recurrent inflammatory fibroid, gastrointestinal | 2024-02-16 | criteria provided, single submitter | clinical testing |